FW: (LML) Ultra-violet radiation, small islands & armadillo corpses

 

Leprosy Mailing List – October 6,  2018

Ref.:   (LML)   Ultra-violet radiation, small islands & armadillo corpses

From:  Joel Almeida, London and Mumbai

---

 

Dear Pieter,

 

M. leprae are known to remain viable for longer in shaded environments than in sunlit environments. Their reduced genome and consequent dependence on catabolic products from host cells paradoxically seems to endow them with the ability to enter a dormant state readily and to survive in that state for months or even longer. The propensity of M. leprae to enter dormancy is capable of explaining many otherwise puzzling features of the epidemiology, microbiology and differential rate of response to bactericidal drugs with duration of treatment.

 

Ultra-violet radiation is capable of disrupting bacterial DNA regardless of the metabolic state of the organism.

 

Therefore, uv radiation seems to deserve a trial as a means of killing dormant but viable M. leprae in shaded environments, both indoors and outdoors. Leprosy hot spots in forested or shaded urban areas of endemic countries might be prime candidates for pilot trials.

 

Wouldn't it be good if uv radiation of the indoor and outdoor environment in the neighbourhood of recognised sources of M. leprae turned out to have a measurable impact on the incidence rate of leprosy among contacts? Trials should help evaluate the potential of this approach.

 

Also, the WHO goodwill ambassador has issued an appeal to help small islands get rid of leprosy. This seems sensible, because it will yield very important lessons about the microbiology and epidemiology whether or not we succeed in eradicating M. leprae from a small island. uv radiation could help there too, in disinfecting areas around known sources of M. leprae.

 

The US-controlled islands that have a high incidence rate of leprosy might well be considered by the CDC USA for a concerted effort at eradication. uv radiation could form part of the effort there too.

 

There may well be other endemic areas or hot spots where uv radiation is worth a trial. Armadillo corpses seem like a prime candidate for this kind of disinfection.

 

uv radiation might reach the M. leprae that remain unaffected by all currently recognised strategies.

 

Joel Almeida

 

Note editor:

Dear colleagues, I will go on holiday till the second week of November. It will not be possible to publish any letter or communication in that period. Sorry for that.

---

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To post to this group, send email to leprosymailinglist@googlegroups.com.
Visit this group at https://groups.google.com/group/leprosymailinglist.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/cb7b4159-cc68-4a58-baec-5e821a1b70a3%40googlegroups.com.
For more options, visit https://groups.google.com/d/optout.

FW: (LML) InfoNTD monthly e-newsletter on NTDs and cross-cutting issues, October 2018

 

Leprosy Mailing List – October 5,  2018

Ref.: (LML)  InfoNTD monthly e-newsletter on NTDs and cross-cutting issues, October 2018

From:  Ilse Egers, Amsterdam, the Netherlands

---

Dear colleagues,

This newsletter provides you with a selection of news items and recent publications on cross-cutting issues in NTDs. Our starting point is to add articles covering a wide variety of issues. Unfortunately, this is not always possible due to a limited diversity in, and shortage of, articles on cross-cutting issues and NTDs.   Feel free to contact us with any questions, or to receive the PDF if a link to the full text is not included. Our document delivery service is free! InfoNTD Survey Because we really like to know what you think of InfoNTD we developed a survey. Your feedback will help us to match your needs. Thanks! Ilse Egers, info@infontd.org InfoNTD Coordinator www.InfoNTD.org

 

 

 

New publications

 

 

Community knowledge and perceptions about Buruli ulcers in Obom Sub-District of the Ga South Municipality in the Greater Accra Region of Ghana. Koka E. Adv Appl Sociol. 2018; 8(9):621-645. Abstract Community knowledge and perceptions of the cause and consequently the appropriate measure to remedy an ailment determine whom people turn to for advice, help, information and treatment when bogged down with a disease. The purpose of the study was to describe community knowledge and perceptions about Buruli ulcer (BU) and how to prevent Buruli ulcer in the Obom sub-district of Ghana. Download PDF Knowledge, stigma, health seeking behaviour and its determinants among patients with post kalaazar dermal leishmaniasis, Bihar, India. Garapati P, Pal B, Siddiqui NA, et al. PLoS ONE. 2018; 13(9):e0203407. Abstract Leishmaniasis is a neglected tropical disease endemic in Bihar, India. Inappropriate health seeking behaviour of post kala-azar dermal leishmaniasis (PKDL) patients may increase the disease duration, severity and transmissibility. Simultaneously, lack of knowledge and perceived stigma may also increase the length of delay in receiving treatment. This ultimately effects the kala-azar elimination program. Download PDF Shadow puppets and neglected diseases: Evaluating a health promotion performance in rural Indonesia. Kurscheid J, Bendrups D, Susilo J, et al. Int J Environ Res Public Health. 2018; 15(9). Abstract 'Rama and the Worm' is a shadow puppet production targeting neglected diseases in Central Java. It is an entertainment-based intervention study to promote health by reducing the impact of parasitic diseases such as soil-transmitted helminths (STH). The study uses traditional Javanese shadow puppetry () as a vehicle in village communities to disseminate health messages and promote behaviour change to prevent diseases caused, primarily, by inadequate sanitation and poor hygiene. Download PDF Implementing active community-based surveillance-response system for Buruli ulcer early case detection and management in Ghana. Ahorlu CSK, Okyere D, Ampadu E. PLoS Negl Trop Dis. 2018; 12(9):e0006776. Abstract Buruli Ulcer (BU) is one of the most neglected debilitating tropical diseases caused by Mycobacterium ulcerans, which causes considerable morbidity and disability. Building on earlier findings that community-based interventions could enhance case detection and reduce treatment dropout and defaulter rates, we established an active surveillance-response system in an endemic sub-district in the Ga West municipality of Ghana to enhance early case detection, diagnosis and treatment to reduce or eliminate severe ulcers and its related disabilities. Download PDF Coinfections and comorbidities in African health systems: At the interface of infectious and noninfectious diseases. Osakunor DNM, Sengeh DM, Mutapi F. PLoS Negl Trop Dis. 2018; 12(9):e0006711. Abstract There is a disease epidemiological transition occurring in Africa, with increasing incidence of noninfectious diseases, superimposed on a health system historically geared more toward the management of communicable diseases. The persistence and sometimes emergence of new pathogens allows for the occurrence of coinfections and comorbidities due to both infectious and noninfectious diseases. There is therefore a need to rethink and restructure African health systems to successfully address this transition. Download PDF Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission. Garchitorena A, Raza-Fanomezanjanahary EM, Mioramalala SA, et al. PLoS Negl Trop Dis. 2018; 12(9):e0006780. Abstract A global strategy of mass drug administration (MDA) has greatly reduced the burden of lymphatic filariasis (LF) in endemic countries. In Madagascar, the National Programme to eliminate LF has scaled-up annual MDA of albendazole and diethylcarbamazine across the country in the last decade, but its impact on LF transmission has never been reported. The objective of this study was to evaluate progress towards LF elimination in southeastern Madagascar. Download PDF Coherence between research output and public health priorities: the case of neglected tropical diseases in Brazil. de Fonseca BP, Albuquerque PC, Zicker F. Leiden University Repository. 2018:1090-1099. Abstract The article contributes to the ongoing discussion on research evaluation, policy priorities, agenda setting and NTD elimination, in alignment with the United Nations sustainable development  goals (SDG 2030). The assessment of coherence between health research promotion and public health needs serves as an important guidance for funders, donors and scientific community. Download PDF Podoconiosis pathogenesis: renewed use of an historical archive. Yardy A, Williams AT, Davey G. Trans. R. Soc. Trop. Med. Hyg. 2018; 112(9):417-418. Read more Feasibility of school-based health education intervention to improve the compliance to mass drug administration for lymphatic Filariasis in Lalitpur district, Nepal: A mixed methods among students, teachers and health program manager. Karki P, Prabandari YS, Probandari A, et al. PLoS ONE. 2018; 13(9):e0203547. Abstract Ensuring reduction in transmission of lymphatic Filariasis (LF) and addressing the compliance of people to mass drug administration (MDA) has led to renewed efforts in the field. School-based health education (SBHE) intervention, considered a cost-effective strategy with potential to reach the wider public through young people, was adopted as a strategy for social mobilization. Download PDF Rural youths' understanding of gene x environmental contributors to heritable health conditions: The case of podoconiosis in Ethiopia. Engdawork K, McBride CM, Ayode D, et al. PLoS Negl Trop Dis. 2018; 12(9):e0006763. Abstract Assess the feasibility of engaging youth to disseminate accurate information about gene by environmental (GxE) influences on podoconiosis, a neglected tropical lymphedema endemic in southern Ethiopia. Download PDF Establishing an international laboratory network for neglected tropical diseases: Understanding existing capacity in five WHO regions. Dean L, Njelesani J, Mulamba C, et al. F1000Res. 2018; 7:1464. Download This study aimed to identify laboratories within five World Health Organisation regions (South-East Asia, Eastern Mediterranean, Americas, Western Pacific and Europe) that provide NTD services and could be regarded as national or regional reference laboratories, and to conduct a survey to document their networks and capacity to support NTD programmes. Download PDF Misconceptions and paradoxes in soil-transmitted helminthiases control as a public health problem. Krolewiecki AJ. PLoS Negl Trop Dis. 2018; 12(9):e0006672. Abstract Soil-transmitted helminthiases (STHs) constitute a public health problem that requires immediate action to resolve the morbidity of those harboring the parasites in their guts, to prevent infection in all those at risk, and to interrupt the vicious circle of poverty and disease in the affected communities, structural poverty being the main determinant of this group of infectious diseases. Download PDF Improving the control of snakebite envenomation in Latin America and the Caribbean: a discussion on pending issues. Gutiérrez JM, Fan HW. Trans. R. Soc. Trop. Med. Hyg. 2018:1-4. Abstract Snakebite envenomations represent a public health problem of great impact, especially in sub-Saharan Africa, Asia, Latin America and some regions of Oceania. In Latin America and the Caribbean, the Pan American Health Organization (PAHO) is building a regional plan to confront this neglected disease. The main pending issues to deal with snakebite envenomation in this region are discussed in this editorial, with the aim of highlighting areas where urgent actions are required. Download PDF CBM Neglected Tropical Diseases – Annual report. CBM. 2018. Download PDF The development of a mobile application to support peripheral health workers to diagnose and treat people with skin diseases in resource-poor settings. Mieras L, Taal A, Post E, et al. Trop Med Infect Dis. 2018; 3(3):102. Abstract Netherlands Leprosy Relief (NLR) has developed a mobile phone application called the 'SkinApp', which aims to support peripheral health workers to recognize the early signs and symptoms of skin diseases, including skin NTDs, and to start treatment promptly or refer for more advanced diagnostic testing or disease management when needed. Further research is needed to determine how greatly mHealth in general and the SkinApp in particular can contribute to improved health outcomes, efficiency, and cost-effectiveness. Download PDF Evaluating temporal patterns of snakebite in Sri Lanka: the potential for higher snakebite burdens with climate change. Ediriweera DS, Diggle PJ, Kasturiratne A, et al. Int J Epidemiol. 2018: 1-10. Abstract Snakebite is a neglected tropical disease that has been overlooked by healthcare decision makers in many countries. Previous studies have reported seasonal variation in hospital admission rates due to snakebites in endemic countries including Sri Lanka, but seasonal patterns have not been investigated in detail. Download PDF Sociocultural dynamics that influence Chagas disease health care in Colombia. Martínez-Parra AG, Pinilla-Alfonso MY, Abadía-Barrero CE. Soc Sci Med. 2018; 215:142-150. Abstract Chagas disease (CD) is a Latin America endemic and neglected tropical disease that affects primarily poor people living in rural areas. Its current low profile leads to many diagnostic, treatment, and control challenges. This study aimed to identify and characterize the sociocultural dynamics that influence CD health care in Colombia. Read more The skin — A common pathway for integrating diagnosis and management of NTDs. Chandler D, Fuller L. Trop Med Infect Dis. 2018; 3(3):101. Abstract Many of the neglected tropical diseases (NTDs) have major skin manifestations. These skin-related NTDs or 'skin NTDs' cause significant morbidity and economic hardship in some of the poorest communities worldwide. We draw attention to the collective burden of skin disease and suggest that the skin be used as a platform for the integration of control activities for NTDs. Download PDF

 

 

News Neglected tropical diseases: treating more than one billion people in 2017 03 October 2017 | Geneva –– The World Health Organization (WHO) has published data for 2017 showing that more than 1 billion individuals were treated during mass drug administration campaigns for at least one of five1 neglected tropical diseases (NTDs) that are amenable to preventive chemotherapy. Read more http://www.who.int/neglected_diseases/news/treating-more-than-one-billion-people-2017/en/   Trachoma elimination: Iranians triumph against the world's leading infectious cause of blindness. 25 September 2018 | Tehran | Cairo | Geneva -- The World Health Organization (WHO) has validated the elimination of trachoma as a public health problem in the Islamic Republic of Iran. Read more http://www.who.int/neglected_diseases/news/Trachoma-Iran-triumph-against-blindness/en/   AfriKADIA https://www.afrikadia.org/ AfriKADIA is a consortium created to find improved treatments and diagnostic tools for visceral leishmaniasis in eastern Africa.

 

 

Events 2018 COR-NTD Meeting https://www.ntdsupport.org/cor-ntd 26 Oct - 27 Oct 2018 | New Orleans, Louisiana The 2018 COR-NTD Meeting will take place in New Orleans, Louisiana on October 26-27 with the theme of "Engage to Eliminate."

 

---

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To post to this group, send email to leprosymailinglist@googlegroups.com.
Visit this group at https://groups.google.com/group/leprosymailinglist.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/bfe3bc6f-a25d-45d7-a407-363045e9eab0%40googlegroups.com.
For more options, visit https://groups.google.com/d/optout.

FW: (LML) Where are the Styblos of leprosy?

 

Leprosy Mailing List – October 4,  2018

Ref.: (LML)  Where are the Styblos of leprosy?  

From:  Joel Almeida, London and Bombai

---

Dear Pieter,

 

In the 1980s self-proclaimed TB experts were celebrating the last mile of TB elimination. New bactericidal drugs would work miracles, according to the promises.

 

Karel Styblo did not join the chorus of celebration. He went to Tanzania and set up a well-documented population-based programme to control TB. Good outcomes were observed quarter after quarter.

 

Arata Kochi at WHO HQ reviewed many TB control programmes across the world and understandably identified Styblo's programme as the best effective option. 

 

In 1993 the WHO officially recognised TB as a global emergency. An updated version of Styblo's programme was devised in the following years, for widespread use. Country after country documented consistently good outcomes. Since then, millions of lives have been saved thanks to this programme.

 

One country, which shall remain unnamed, was slow to adopt the strategy. Their reason? TB had almost been eliminated in their country. It was a false boast. Their slowness to admit the real epidemiological situation was responsible for a huge number of unnecessary deaths.

 

In leprosy we still have people so busy congratulating themselves over imaginary successes that patients continue to be neglected. They too often suffer unnecessary disfigurement and disability despite treatment. Isn't it time for the self-congratulatory posturing to give way to better care for patients, so that they can be protected against avoidable disfigurement?

 

New thinking and a fresh start would help, without attachment to past errors. How do we attract bright young people to leprosy work?

 

Think back to how you became interested in leprosy. For me, it was a simple question from Dr. Job, the pathologist. "Would you like to work in leprosy?" Combined with a specific opportunity.

 

We need Styblos in leprosy. People who will integrate fragments of scientific knowledge into coherent and effective front-line interventions to protect people against disfigurement by leprosy. These pioneers need to be on the ground in core-funded population-based programmes that rigorously document successes and failures. Then they can tweak operations continuously to improve outcomes.

 

Then we will have a real chance of devising programmes capable of protecting people reliably against the disfigurements of leprosy. 

 

We need to create opportunities and ask bright young people the simple question, "Would you like to work in leprosy?" M. leprae is a slippery foe, because it can play dead for months or even years at a time. The disfigurements arise not only from bacterial proliferation but also inflammatory responses. Isn't this a fascinating challenge for bright young minds, unattached to past errors? Aren't there plenty of bright young minds in India, Brazil, Indonesia and other leprosy endemic countries? Don't such countries export intellectual firepower, and have exemplary people of compassion working on the front lines? Can't we create more opportunities for bright young people in the leprosy endemic countries?

 

For the past few decades we have too often been content to congratulate ourselves and boast, sometimes even suppressing inconvenient evidence. Some of the worst offenders have been those who make exaggerated claims and predictions about M. leprae disappearing, in the process repelling young people from leprosy work. Isn't it time to devise measurably effective programmes instead? Isn't it time for Styblos in leprosy? Isn't it time to core-fund a few large population-based field programmes, that can evolve demonstrably effective programmes and test a wide variety of interventions?

 

Our past habits made the future bright for M. leprae. Let's make it bright for the people of leprosy-endemic countries instead. Let's keep drawing bright young talent into leprosy work at the front lines, and fund population-based field programmes that are continuously improved and rigorously documented.

 

Joel Almeida

---

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To post to this group, send email to leprosymailinglist@googlegroups.com.
Visit this group at https://groups.google.com/group/leprosymailinglist.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/821d345f-8662-47a9-a7f5-1d7b4c6bae11%40googlegroups.com.
For more options, visit https://groups.google.com/d/optout.

FW: (LML) Infolep monthly update with a selection of leprosy publications – October 2018

 

Leprosy Mailing List – October 3,  2018

Ref.:    (LML)  Infolep monthly update with a selection of leprosy publications – October 2018

From:  Jiske Erlings, Amsterdam, the Netherlands

---

Dear colleagues,

On a monthly basis we keep you up-to-date with scientific publications on leprosy and related subjects, recently added to the Infolep portal. Feel free to contact me for full text versions if a link to the full text is not included or for assistance with your literature research. To improve the availability of leprosy research in other languages than English we now have Google Translate's automated translations built into the Infolep portal (in the "markedly better than nothing" category). If you try this for your language, please let me know if this works for you. Jiske Erlings, j.erlings@leprastichting.nl Infolep Information officer

 

 

Highlighted publications

 

 

Global leprosy update, 2017: reducing the disease burden due to leprosy. Wkly Epidemiol Rec. 2018 Aug 31;93(35):445-456. Download Also see the separate Table 7: Global leprosy situation by WHO region, country and territories, 2017. Download WHO Guidelines on leprosy diagnosis, treatment and prevention. Download

 

 

New publications

 

 

Saphenous nerve transfer: A new approach to restore sensation of the sole. Agarwal P, Shukla P, Sharma D. J Plast Reconstr Aesthet Surg. 2018. Read abstract   The spatial pattern and risk factors of leprosy occurrence in barru, Indonesia. Mallongi A, Handayani, Selomo M et al. Ind. Jour. of Publ. Health Rese. & Develop. 2018. (8). 1489-1494. Read abstract   Phenotypic and functional features of innate and adaptive immunity as putative biomarkers for clinical status and leprosy reactions. Campos de Carvalho J, Araújo MG, Alves Coelho-Dos-Reis JG, et al. Microb. Pathog. 2018. Read abstract   Lessons from leprosy: peripheral neuropathies and deformities in chronic demyelinating diseases. Chan JP, Uong J, Nassiri N, et al. J Hand Surg Am. 2018. Read abstract   Evaluation of antigen-specific immune responses for leprosy diagnosis in a hyperendemic area in China. Chen X, You YG, Yuan YH, et al. PLoS Negl Trop Dis. 2018 Sep 24;12(9):e0006777. Download PDF   Worsening of the disability grade during leprosy treatment: prevalence and its determinants in Southern Nigeria. Chukwu JN, Ekeke N, Nwafor CC, et al. Trans R Soc Trop Med Hyg. 2018 Sep 5. Read abstract   Borderline Lepromatous Leprosy: Uncommon Clinical Presentation. Elwan NM, Neinaa YME. Am J Dermatopathol. 2018 Sep 11. Read abstract   Armadillos bring risk of leprosy. Friedrich MJ. JAMA Netw Open. 2018; 320(11):1097. Download PDF   Evaluation of Auramine O staining and conventional PCR for leprosy diagnosis: A comparative cross-sectional study from Ethiopia. Girma S, Avanzi C, Bobosha K, et al. PLoS Negl Trop Dis. 2018; 12(9):e0006706. Download PDF   Perception toward the disease of the people affected by leprosy. Govindharaj P, Srinivasan S, Darlong J. Int J Mycobacteriol. 2018 Jul-Sep;7(3):247-250. Download PDF   Trends of leprosy in pre and post elimination era - A statistical and clinical update. Kamoji S, Dastikop S, Kumar N. IJCED. 2018; 4(1) 26-29. Download PDF   Relationship between intensity and humidity with leprosy in the city of Semarang Central Java. Kobis IW, Suhartono, Wahyungisih NE. Int. J. Adv. Res. Sci. Eng. Technol. 2018; 5(8):6499-6502. Download PDF   The spatial pattern and risk factors of leprosy occurrence in barru, Indonesia. Mallongi A, Handayani, Selomo M, et al. Ind. Jour. of Publ. Health Rese. & Develop. 2018; 9(8):1489-1494. Read abstract   The development of a mobile application to support peripheral health workers to diagnose and treat people with skin diseases in resource-poor settings. Mieras L, Taal A, Post E, Ndeve A, van Hees C. Trop Med Infect Dis. 2018; 3(3): 102. Download PDF   Coinfections and comorbidities in African health systems: At the interface of infectious and noninfectious diseases. Osakunor DNM, Sengeh DM, Mutapi F. PLoS Negl Trop Dis. 2018 Sep 20;12(9):e0006711. Download PDF   A scoping review on the field validation and implementation of rapid diagnostic tests for vector-borne and other infectious diseases of poverty in urban areas. Osorio L, Garcia JA, Parra LG, et al. Infect Dis Poverty. 2018 Sep 3;7(1):87. Download PDF   Sparfloxacin-induced photo-onycholysis and photosensitivity characteristically sparing lepromatous skin lesions: an interesting observation. Pawar M, Singh M. Acta Dermatovenerol Alp Pannonica Adriat. 2018 Sep;27(3):149-151. Download PDF   Prevention of Strongyloides stercoralis hyperinfection in leprosy patients on long-term steroid therapy. Prabha N, Chhabra N. Indian J Dermatol Venereol Leprol. 2018 Sep 12. Read abstract   Oral manifestation of leprosy: A clinicopathologic study of 13 cases. Rodrigues GA, Qualio NP, Innocentini LMAR, et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018; 126(3):e42. Read abstract   A 13-year-old with coexistence of gastric volvulus and leprosy: A case report of two rare entities. Schneider J, Mays R. Case Rep Infect Dis. 2018; 2018:5. Download PDF   [A case series of pure neural leprosy in patients diagnosed in a specialized center for the control of Hansen's disease in Colombia]. Serrano-Coll H, Mieles O, Escorcia C, et al. Biomedica. 2018; 38(2):153-161. Download PDF   Potential of AKR1B10 as a biomarker and therapeutic target in type 2 leprosy reaction. Soares CT, Fachin LR, Trombone APF, et al. Front Med (Lausanne). 2018. Read abstract   Development and validation of a scale to assess attitudes of health care providers towards persons affected by leprosy in southern India. Srinivas G, Kumar S, Mohanraj R, et al. PLoS Negl Trop Dis. 2018 Sep 25;12(9):e0006808. Download PDF   [Leprosy and ganglionar tuberculosis coinfection in an adult]. Tablada MER, Marrero HR, López NP. MEDISAN. 2018; 22(7):559-566. Download PDF   Target Hansen's disease. Thangaraju P, Venkatesan S, Sivashanmugam E, et al. J Family Med Prim Care. 2018 Jul-Aug;7(4):838. Download PDF   Prediction of leprosy in the Chinese population based on a weighted genetic risk score. Wang N, Wang Z, Wang C, et al. PLoS Negl Trop Dis. 2018 Sep 19;12(9):e0006789. Download PDF   Leprosy diagnosed via teledermatology in a U. S. urban academic health center highlights potential benefits and a pitfall of existing telemedicine services. Watchmaker L, Watchmaker J, DeLeon D, et al. Telemed J E Health. 2018 Sep 12. Read abstract   Web-based health databases and real-time GIS-based disease surveillance for leprosy control: fighting ancient evil with modern tools. Wijesinghe MSD. J Coll Community Phys Sri Lanka. 2018; 24(2):123-126. Download PDF   The correlation of the level of community knowledge and education with the level of leprosy occurrence in Central Jakarta area year 2017. Zahra M, Setiasih NL, Bubakar AHA. J Current Med Res Opinion. 2018; 1(6):29-33. Download PDF

 

 

Journals & Newsletters

 

 

Disability, CBR & Inclusive Development: http://dcidj.org/ Hansenologia Internationalis: http://www.ilsl.br/revista/atual.php Indian Journal of Leprosy: http://www.ijl.org.in/index.html  Leprosy Review: https://www.lepra.org.uk/Pages/FAQs/Category/volume-89 Leprosy Review Repository (1928-2001) : http://leprev.ilsl.br/arquivo.php Plos Neglected Tropical Diseases: http://journals.plos.org/plosntds/   Revista de Leprología: http://www.leprosy-information.org/resource/revista-de-leprologia   WHO Goodwill Ambassador's Newsletter for the elimination of leprosy: http://www.smhf.or.jp/e/ambassador/index.html

 

 

Websites & Services

 

 

WHO Global Leprosy Programme http://www.who.int/lep/en/ & http://www.searo.who.int/entity/global_leprosy_programme/en/ The Global Partnership for Zero leprosy http://zeroleprosy.org/ LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in this theme to share ideas, information, experiences and questions. https://groups.google.com/forum/#!forum/leprosymailinglist InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs) https://www.infontd.org/

 

 

GDPR & the Infolep newsletter

 

 

New EU data protection regulations came into force on 25 May. We have been reviewing our practices with regards to the GDPR, including our privacy statement and mailing list. Infolep sends out monthly e-mails to its subscribers with an overview of recent publications on leprosy. The purpose of this activity is to keep subscribers up to date. Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else. We hope the content from the Infolep newsletter is useful to you, but you can update your preferences or unsubscribe from this list at any time.   LML - S Deepak, B Naafs, S Noto and P Schreuder LML blog link: http://leprosymailinglist.blogspot.it/ Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To post to this group, send email to leprosymailinglist@googlegroups.com.
Visit this group at https://groups.google.com/group/leprosymailinglist.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/4e9a023a-1618-4d2c-a1e0-02bb63b46a14%40googlegroups.com.
For more options, visit https://groups.google.com/d/optout.